David E. Coury, PHARM. D.

*** ***** *****, ***********, ** 190**-***-*** 6851 ad25kb@r.postjobfree.com www.linkedin.com/in/david-coury SUMMARY

Hospital Related Experiences and Transferrable Skills for Per Diem Hospital Pharmacist Position. Six years of cumulative hospital staff pharmacy experience including ICU hospital and Pharmacy P&T committee responsibilities. Other diverse related pharmacy experiences include managed care formulary and utilization management for health plans and pharmacy benefit managers. Expertise in data driven drug spend analysis and cost saving solutions to improve medication coverage benefit cost effectiveness, clinical efficacy, and utilization, especially for specialty drugs. Help develop and evolve unique clinic pharmacy service models for Federally Qualified Health Centers.

Deep related expertise in:

• Oral and IV medication Order Entry • Medication Carts Checks

• Pharmacy Technician Supervision • Injectables & Specialty Drugs

• Pharmacy & Therapeutics Committee Expertise • ICU pharmacy Services

• Data Analytic Driven Cost Saving Solutions • Medication & Healthcare Trends

• Subject Matter Presentations • Clinical Program Development

• Pharmaceutical Channel & Market Access • Problem Solving PROFESSIONAL EXPERIENCE

NUVEM, Mt. Laurel, NJ / Sharon Hill, PA 2022 – 2023 In 2022 Apovia merged with 340B Technologies (DBA 340Basics) to formulate a new company called Nuvem. Nuvem’s Industry leading 360-degree comprehensive 340B pharmacy service model helps optimize the financial viability of FQHCs, improve patient clinical outcomes and maintain strict 340B regulatory compliance. Vice President of Pharmacy Development

Played a pivotal role in the successful integration of Apovia and 340Basics to formulate the newly branded company called Nuvem. As VP of Pharmacy Development was the principal author in drafting the value messaging used to market and sell in-house pharmacy services by the Nuvem sales and marketing team.

• Sold and procured inhouse pharmacy management service agreements with 3 Federally Qualified Health Centers customers and successfully presented to support sales team efforts for inhouse pharmacy services with 2 other FQCHs with a collective annual projected revenue of $3.5 M. APOVIA PHARMACY SERVICES, Sharon Hill, PA 2018 – 2022 Specialized in setting up and managing in-house pharmacy services for Federal Qualified Health Centers. Instituted a comprehensive service model designed to optimize 340B revenues and patient clinical outcomes. President and Chief Pharmacy Officer

Oversaw the development and implementation of a successful pharmacy service offering that complemented the medical home model followed by Federally Qualified Health Centers to improve the medication needs of the FQHC patients and generate needed revenues to help expand and improve access to medical services for the underserved. The success of this model is evidenced in the growth of Apovia’s revenues.

• Spear headed business development activities that more than doubled the company revenue from $4.1 million to $8.7 million and increased EBITDA margin from 18% to 25%. within 3 years.

• Instituted 2 successful clinical pharmacist programs to provide direct and population-based care for a remote blood pressure monitoring hypertension program and a clinical diabetes clinical program. The HTN program improved HTN control from 40% control for all hypotensive patients to 70% in 1 years from the start of the program

David E. Coury, PHARM. D. Page 1

ACRO PHARMACEUTICAL SERVICES, Sharon Hill, PA 2008 – 2018 Specialty pharmacy that offers customized services and cost-effective healthcare management solutions to payers, pharmaceutical manufacturers, providers and patients. Vice President, Business Development

Led business development strategy, identifying synergistic opportunities with current and new customers to expand service capabilities and improve operational efficiencies. Managed a team of three in pharmacy client relations and contract management. Contributed to annual specialty pharmacy revenue growth from $12M to $220M over nine years.

• Procured 33+ drug manufacturing contracts ranging from access to limited distribution medications, data service fees, clinical service fees and payer formulary rebate management resulting in $1M+ high margin annual revenue.

• Evolved business model from an exclusive pharmacy provider in narrow payer networks to larger network presence. Increased payer network status: Commercial insurers- 100%, Tricare- 200%, Medicaid- 200%, Medicare Part D- 30%.

• Supported the marketing and sale of the company twice, in 2011 for a sale price of $33M and in 2016 for $75M.

• Increased industry awareness of the company by creating and managing program content for 8 Managed Care Specialty Pharmacy Symposiums, 16 company sponsored health care programs and 10+ industry conference presentations.

• Developed moderator guides for 20+ specialty pharmacy advisory programs and conference panel discussions for key health care stakeholders on coverage and spending trends, impact of health care regulatory reforms. JERINI US, INC., Morristown, NJ 2007 – 2008

Subsidiary of Jerini AG, a privately held pharmaceutical company based in Berlin, Germany, focused on the discovery and development of novel peptide-based drugs.

Medical Service Liaison (MSL)

Conducted pre-launch activities in a 12 state service area to prepare the market for the introduction of the company’s first pharmaceutical product, Icatibant. Responsibilities included engaging Key Opinion Leaders

(KOLs)- allergists, hospital pharmacy directors, emergency room physicians - that treat patients with the ultra- orphan disease, Hereditary Angiodema (HAE) to raise awareness of the role Icatibant, a Bradykinin 2 blocker, could play in the management of HAE.

• Facilitated a two-way scientific exchange with KOLs relating to the pathology and treatment options for HAE to create market awareness for Icatibant through meetings, conferences.

• Developed a market research strategy to identify the number of HAE patients in the MSL service areas which increased identified patients from 200 to 2000+.

• Created market intelligence reports that included identified HAE patients, allergists educated on bradykinin blocker role in managing pathological effects of bradykinin in HAE and feedback from KOLs to strategically guide marketing efforts.

PERFORMRX / AMERIHEALTH MERCY, Philadelphia, PA 1999 - 2007 PerformRx is a pharmacy benefits manager (PBM) dedicated to clinical culture, boutique service and holistic solutions. Manager of Injectable and Specialty Drug Clinical Programs Managed and trained a staff of five pharmacy technicians, three pharmacists and one nurse case manager in managing specialty drug coverage operations. Developed and presented at P&T Committees injectable medication prior authorization protocols and formulary reviews based on clinical efficacy, safety and cost.

• Generated $3M in annual drug cost savings through effective prior authorization, formulary management, distribution coordination with specialty pharmacy networks and nurse case management for Medicaid health plans for 750K lives.

• Developed 10+ comprehensive medical management cost saving strategies for the most expensive specialty medication therapeutic classes used to treat a variety of diseases including Hepatitis B and C, Pulmonary Hypertension, RSV, HIV, etc.

• Streamlined pharmacy claims system to increase efficiency of generic injectable medication prior authorization process. Reduced department workload, increased patient access to medications and improved pharmacy billing.

David E. Coury, PHARM. D. Page 2

GERMANTOWN HOSPITAL AND COMMUNITY HEALTH SERVICES, Philadelphia, PA 1997 – 1999 Critical Care Pharmacist, ICU

Provided clinical support to ICU medical team regarding patient medication decisions and pharmacy and therapeutics committee medication reviews for formulary placement consideration.

• Trained 20 ICU resident physicians and interns and 15 nursing staff on pharmacy therapeutic policy updates and quality improvement initiatives.

• Revised long-term care pharmacy consultant drug review checklists to ensure compliance with federal dispensing regulations and distribution system integrity audits.

• Served on Albert Einstein Medical Center Risk Task Force Committee. Reviewed drug utilization data analysis reports to improve cost effective drug therapy. Developed disease state management programs for physician education.

NEIGHBOR CARE, King of Prussia, PA 1994 – 1997

Clinical Consultant Pharmacist

Managed seven nursing home accounts to evaluate and managed compliance with Federal Unnecessary Drug regulations and industry recognized standards of drug dispensing care.

• Implemented successful behavioral management and quality improvement initiatives that reduced psychotropic drug utilization to below industry norms.

• Provided in-service programs to nursing home staff to identify areas for quality improvement in drug dispensing. Easton Hospital, Easton, PA 1991 – 1994

Staff Pharmacist

Performed prescription entry of oral, IV admixture medications, TPN and all other necessary hospital administered medications. Supervised pharmacy technicians relating to all aspects of pharmacy technical support. Checked medication carts and performed necessary medication inspections. Responded to all physician and nursing pharmacy related questions and inquiries having anything to do with pharmacy services. EDUCATION / LICENSURE

Doctor of Pharmacy, Temple University School of Pharmacy, Philadelphia, PA Bachelor of Science in Pharmacy, Philadelphia College of Pharmacy and Science, Philadelphia, PA Bachelor of Science in Biochemistry, Alvernia College, Reading, PA Licensed Registered Pharmacist, Commonwealth of Pennsylvania, 1991- Present National Association of Pharmaceutical Representatives – Certified National Pharmaceutical Representative

(CNPR Certification Number: 713052024)

Microsoft Learn: Completed 8 Microsoft Modules on Artificial Intelligence (AI) Principles and Applications PROFESSIONAL AFFILIATIONS

• National Association of Specialty Pharmacy, Clinical Committee Member

• Philadelphia School of Pharmacy, Preceptor

• Academy of Manager Care Pharmacy, Member • Asembia, Presenter, Asembia Conference

• Pharmacy & Therapeutics Committee, PerformRx, Germantown Hospital

• ICU Committee, Germantown Hospital

• Disease State Mgt Steering & Cost Containment Committee, Keystone Mercy Health Plan

• National Association of Pharmaceutical Sales

Representatives

OTHER ACTIVITIES / SKILLS

• Judge of Elections / Springfield PA, Delaware County, 7th Ward, 2nd Precinct. 11/2020 – Present

• Proficient in Microsoft Word, Power Point and Excel. David E. Coury, PHARM. D. Page 3

PRESENTATIONS

Aug 2022 “Apovia’s Superior On-Site Pharmacy Solution” Company Sponsored Webinar Aug 2021 “Essential Strategies for 340B / Dinner and Panel Discussion” Presenter and Moderator, Apovia Sponsored Event at the National Association of Community Health Centers (NACHC) Sept 2021 “Inhouse Pharmacy Services – Optimizing Opportunities / Challenges” Web Presentation at Mid-Atlantic Association of Community Health Centers (MACHC).

June 2021 “340B Pharmacy – Perspectives for Financial Investors” Panelist, PJ Solomon and Apovia Sponsored Webinar Event.

Dec 2019 Moderator “Exclusive Apovia Sponsored Payer Panel Discussion” Moshulu Restaurant, Philadelphia PA Sept 2018 “2 + 2 = 3: Why Copay Accumulator Programs Don’t Add Up for Patients” 6th Annual National Association of Specialty Pharmacy Annual Meeting and Educational Conferences. Washington DC June 2017 Healthcare Delivery Trends Impacting Specialty Pharmacy and Pharma, 2017 Asembia Annual Specialty Pharmacy Conference.

May 2016 Pharma’s Challenges to Limit High Drug Prices & Participate in Value-Based Agreements & the Impact on Specialty Pharmacy, 2016 Armada Annual Specialty Pharmacy Conference. June 2015 Moderator for Panel Discussion: Payer Perspective on Biosimilars, Biosimilar 20/20 Conference, Sponsored by Specialty Pharma Education Center (SPEC). May 2015 The Impact of the Affordable Care Act (ACA) on Patient Access to Specialty Medications and the Business of Specialty Pharmacy and Pharma: An Unconventional View, 2015 Armada Annual Specialty Pharmacy Conference.

May 2014 340B Hospital Pricing Program: Impact on the Healthcare Landscape, 2014 Armada Annual Specialty Pharmacy Conference.

Dec 2013 Moderator of Pharma Panel: Role of Specialty Data in Care Coordination Across the Patient Journey, CBI Specialty Data Optimization Summit.

May 2013 Moderator of Payer Panel: Payer Perspective on the Affordable Care Act, 2013 Armada Annual Specialty Pharmacy Conference.

May 2012 A Payer Perspective on Biosimilars, 2012 Armada Annual Specialty Pharmacy Conference. May 2011 Payer Strategies for Managing Specialty Medication Coverage, 2011 Armada Annual Specialty Pharmacy Conference.

Sept 2006 Applying Evidence Based Medicine To Cost Effectively Manage High Cost Specialty Injectable Medications, Audio Conference sponsored by Atlantic Information Services, Inc. June 2006 Reducing High Cost Injectable Spending in an Era of High Demand, Americas Health Insurance Plans

(AHIP) Conference.

May 2006 Payers Perspective on Providing a Hemophilia Benefit, Hemophilia Alliance 4th Annual Conference. Sept 2005 Formulating an Administrative, Operational, and Clinical Management Strategy for Specialty Drugs that is Responsive to MMA Requirements and Goals, Medicare Conference. David E. Coury, PHARM. D. Page 4

Contact this candidate